Investigators conducted a retrospective study of patients treated for early-stage breast cancer at Fred Hutch Cancer Center to identify clinicopathologic factors associated with SLN-positivity (SLN+), ...

Investigators conducted a cross-sectional survey to identify factors associated with psychological hardship related to the ...

Researchers conducted a pan-cancer analysis to examine the sex-based differences in cancer stage at diagnosis for various cancer sites.

The anti–lymphocyte activation gene 3 (LAG-3) antibody relatlimab demonstrated acceptable safety with or without nivolumab, and also provided preliminary immunologic and clinical findings for patients ...

Investigators saw strong correlation between TTF and PFS for patients with poor prognosis and good prognosis. Time to treatment failure (TTF) is associated with progression-free survival (PFS) across ...

Eighty countries and territories, accounting for 39.60 percent of the world, exhibit overlapping breast cancer (BC) and atrial fibrillation (AF) incidence, according to a study published online July 8 ...

The researchers designed this retrospective cohort study to examine the effect of demographics, including race/ethnicity, insurance status, age, and geographic location, on prostate cancer screening ...

Rates of prostate cancer screening shared decision-making (SDM) are very low in family medicine practices, according to a study published in the June issue of the Southern Medical Journal. Nicholas ...

CEBPA mutations in MDS are uncommon but associated with shorter survival and an increased risk of AML transformation.

Investigators conducted this cross-sectional secondary analysis using baseline data from a phase 3 randomized controlled trial to explore associations between fear of cancer recurrence and coping ...

A quality improvement study analyzed the value of advanced telehealth delivery methods during prostate cancer management.

In this long-term follow-up to the phase 2 ARTO trial, researchers analyzed survival outcomes in patients with CRPC treated with metastasis-directed therapy.